OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
Domenica Rubino, Frank L. Greenway, Usman Khalid, et al.
JAMA (2022) Vol. 327, Iss. 2, pp. 138-138
Open Access | Times Cited: 575
Domenica Rubino, Frank L. Greenway, Usman Khalid, et al.
JAMA (2022) Vol. 327, Iss. 2, pp. 138-138
Open Access | Times Cited: 575
Showing 51-75 of 575 citing articles:
Efficacy and safety of tirzepatide, GLP ‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
Xin‐Hui Pan, B.C. Tan, Yip Han Chin, et al.
Obesity (2024) Vol. 32, Iss. 5, pp. 840-856
Closed Access | Times Cited: 18
Xin‐Hui Pan, B.C. Tan, Yip Han Chin, et al.
Obesity (2024) Vol. 32, Iss. 5, pp. 840-856
Closed Access | Times Cited: 18
Therapeutic advances in obesity management: an overview of the therapeutic interventions
Moody Al Roomy, Kainat Hussain, Hawraa M. Behbehani, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 17
Moody Al Roomy, Kainat Hussain, Hawraa M. Behbehani, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 17
Obesity and cardiovascular disease: an ESC clinical consensus statement
Konstantinos C. Koskinas, Emeline M. Van Craenenbroeck, Charalambos Antoniades, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 16
Konstantinos C. Koskinas, Emeline M. Van Craenenbroeck, Charalambos Antoniades, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 16
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
Areesha Moiz, Kristian B. Filion, Helia Toutounchi, et al.
Annals of Internal Medicine (2025) Vol. 178, Iss. 2, pp. 199-217
Closed Access | Times Cited: 5
Areesha Moiz, Kristian B. Filion, Helia Toutounchi, et al.
Annals of Internal Medicine (2025) Vol. 178, Iss. 2, pp. 199-217
Closed Access | Times Cited: 5
Revised definition of obesity in Asian Indians living in India
Anoop Misra, Naval K. Vikram, Amerta Ghosh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025), pp. 102989-102989
Closed Access | Times Cited: 3
Anoop Misra, Naval K. Vikram, Amerta Ghosh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025), pp. 102989-102989
Closed Access | Times Cited: 3
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses
Mikhail Kosiborod, Meena Bhatta, Melanie J. Davies, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 2, pp. 468-478
Open Access | Times Cited: 59
Mikhail Kosiborod, Meena Bhatta, Melanie J. Davies, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 2, pp. 468-478
Open Access | Times Cited: 59
FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade
Zarwa Idrees, Ivan Cancarevic, Li Huang
Cureus (2022)
Open Access | Times Cited: 56
Zarwa Idrees, Ivan Cancarevic, Li Huang
Cureus (2022)
Open Access | Times Cited: 56
Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program
Carel W. le Roux, Shuyu Zhang, Louis J. Aronne, et al.
Obesity (2022) Vol. 31, Iss. 1, pp. 96-110
Open Access | Times Cited: 55
Carel W. le Roux, Shuyu Zhang, Louis J. Aronne, et al.
Obesity (2022) Vol. 31, Iss. 1, pp. 96-110
Open Access | Times Cited: 55
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review
Zeyu Xie, Sensen Yang, Weishang Deng, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 1463-1476
Open Access | Times Cited: 54
Zeyu Xie, Sensen Yang, Weishang Deng, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 1463-1476
Open Access | Times Cited: 54
Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
Xueqin Gao, Xiaoli Hua, Xu Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Xueqin Gao, Xiaoli Hua, Xu Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Harold Bays, Angela Fitch, Sandra Christensen, et al.
Obesity Pillars (2022) Vol. 2, pp. 100018-100018
Open Access | Times Cited: 47
Harold Bays, Angela Fitch, Sandra Christensen, et al.
Obesity Pillars (2022) Vol. 2, pp. 100018-100018
Open Access | Times Cited: 47
GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?
Maurício Reis Pedrosa, Denise Reis Franco, Hannah Waisberg Gieremek, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 11, pp. 867-884
Closed Access | Times Cited: 47
Maurício Reis Pedrosa, Denise Reis Franco, Hannah Waisberg Gieremek, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 11, pp. 867-884
Closed Access | Times Cited: 47
New therapies for obesity
Dimitris Papamargaritis, Carel W. le Roux, Jens J. Holst, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 18, pp. 2825-2842
Open Access | Times Cited: 41
Dimitris Papamargaritis, Carel W. le Roux, Jens J. Holst, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 18, pp. 2825-2842
Open Access | Times Cited: 41
Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States
Nina Kim, Jessie Wang, Chakkarin Burudpakdee, et al.
Journal of Managed Care & Specialty Pharmacy (2022) Vol. 28, Iss. 7, pp. 740-752
Open Access | Times Cited: 40
Nina Kim, Jessie Wang, Chakkarin Burudpakdee, et al.
Journal of Managed Care & Specialty Pharmacy (2022) Vol. 28, Iss. 7, pp. 740-752
Open Access | Times Cited: 40
Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations
Ariana M. Chao, Jena Shaw Tronieri, Anastassia Amaro, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 4449-4461
Open Access | Times Cited: 38
Ariana M. Chao, Jena Shaw Tronieri, Anastassia Amaro, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 4449-4461
Open Access | Times Cited: 38
A narrative review of approved and emerging anti-obesity medications
Semira Abdi Beshir, Asim Ahmed Elnour, Aadith Soorya, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 10, pp. 101757-101757
Open Access | Times Cited: 36
Semira Abdi Beshir, Asim Ahmed Elnour, Aadith Soorya, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 10, pp. 101757-101757
Open Access | Times Cited: 36
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis
Huzaifa Ul Haq Ansari, Shurjeel Uddin Qazi, Faiza Sajid, et al.
Endocrine Practice (2023) Vol. 30, Iss. 2, pp. 160-171
Closed Access | Times Cited: 35
Huzaifa Ul Haq Ansari, Shurjeel Uddin Qazi, Faiza Sajid, et al.
Endocrine Practice (2023) Vol. 30, Iss. 2, pp. 160-171
Closed Access | Times Cited: 35
Semaglutide and cancer: A systematic review and meta-analysis
Lakshmi Nagendra, BG Harish, Meha Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 9, pp. 102834-102834
Closed Access | Times Cited: 34
Lakshmi Nagendra, BG Harish, Meha Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 9, pp. 102834-102834
Closed Access | Times Cited: 34
A Comprehensive Review on Weight Loss Associated with Anti-Diabetic Medications
Fatma Haddad, Ghadeer Dokmak, Maryam Bader, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1012-1012
Open Access | Times Cited: 33
Fatma Haddad, Ghadeer Dokmak, Maryam Bader, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1012-1012
Open Access | Times Cited: 33
Glucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes: An Updated Systematic Review and Meta-analysis
Jeayoung Park, Spyridon Ntelis, Elvina Yunasan, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. 279-292
Open Access | Times Cited: 31
Jeayoung Park, Spyridon Ntelis, Elvina Yunasan, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. 279-292
Open Access | Times Cited: 31
Current and future pharmacotherapies for obesity in children and adolescents
Aaron S. Kelly
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 9, pp. 534-541
Closed Access | Times Cited: 28
Aaron S. Kelly
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 9, pp. 534-541
Closed Access | Times Cited: 28
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Nik Krajnc, Bianca Itariu, Stefan Macher, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 27
Nik Krajnc, Bianca Itariu, Stefan Macher, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 27
GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes
Sydney S. Wilbon, Mikhail G. Kolonin
Cells (2023) Vol. 13, Iss. 1, pp. 65-65
Open Access | Times Cited: 27
Sydney S. Wilbon, Mikhail G. Kolonin
Cells (2023) Vol. 13, Iss. 1, pp. 65-65
Open Access | Times Cited: 27
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
Christine R. Andreasen, Andreas Andersen, Tina Vilsbøll
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1846-1858
Open Access | Times Cited: 26
Christine R. Andreasen, Andreas Andersen, Tina Vilsbøll
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1846-1858
Open Access | Times Cited: 26
Case Report: Semaglutide-associated depression: a report of two cases
Jiarui Li, Jinya Cao, Jing Wei, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 26
Jiarui Li, Jinya Cao, Jing Wei, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 26
